Sign in
Taking people in United StatesNo phase

Imaging Airflow Behind Mucus Plugs in Lung Disease With Xenon MRI

Uses xenon MRI to study airflow in lung areas behind mucus plugs in adults.

Key facts

Who runs it
University of Kansas Medical Center
Where
Kansas City, United StatesSee the site
Trial code
Registry title
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Status
Recruiting
People taking part
8 people, planned
Started
1 Jun 2025
Expected to end
Dec 2026
Type of study
Observational
Treatments tested
  • Hyperpolarized 129 Xenon
Record updated
1 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 with a long-standing lung disease that causes mucus build-up: cystic fibrosis, severe asthma, COPD or non-cystic fibrosis bronchiectasis.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
A doctor's diagnosis of cystic fibrosis, severe asthma, COPD or non-cystic fibrosis bronchiectasis for more than 1 year.
Earlier treatment
One-time doses such as joint injections need a 4-week break before the first visit. No use of investigational drugs in the past 30 days.
Biomarker or test result
Able to do repeatable breathing tests (spirometry) that meet ATS criteria.

Main reasons for not taking part

  • Lung or airway infection in the 4 weeks before the first visit
  • Body mass index (BMI) above 30
  • Emergency room visit for the lung condition in the past 4 weeks
  • Other serious illness, such as heart disease, cancer or uncontrolled diabetes
  • A positive urine pregnancy test

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Adequate completion of informed consent process with written documentation
  • Patients 18 - 65 years old
  • • Physician diagnosis of muco-obstructive pulmonary disease, including cystic fibrosis, severe asthma, chronic obstructive pulmonary disease, or non-cystic fibrosis bronchiectasis for > 1 year
  • Able to perform reproducible spirometry according to ATS criteria based on clinical PFTs

Who cannot take part

  • Respiratory tract infection within the 4 weeks prior to Visit 1
  • One-time doses such as intra-articular injections require a 4-week washout prior to Visit 1
  • ER visit related to pulmonary condition within the previous 4 weeks of Visit 1
  • Significant concomitant medical illness, including (but not limited to) heart disease, cancer, uncontrolled diabetes, other chronic lung diseases (determined by the Investigator.)
  • Participation in an intervention study (including bronchoscopy) or use of investigative drugs within the past 30 days or plans to enroll in such a trial during the study
  • Conditions that will prohibit MRI scanning determined by the MRI safety screening
  • Body mass index (BMI) > 30 at Visit 1
  • Resting O2 saturation <90% with maximum supplemental O2 delivered by nasal canula
  • Positive urine pregnancy test
  • Unable or unlikely to complete study assessments in the opinion of the Investigator
  • Study intervention poses undue risk to patient in the opinion of the Investigator

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of Kansas Medical CenterKansas City, United StatesContact: Cristal MongeTaking people

About the trial

What the trial wants to find out

In this study, xenon MRI will be used to evaluate regional functional consequences of mucus plugs in the lungs of patients with muco-obstructive pulmonary disease. Mucus plugs will be identified using CT imaging, and xenon MRI will be used to evaluate ventilation and gas exchange impairments in regions of the lungs corresponding to the airways downstream of mucus plugs.

The group in the trial

  • Main Group

    Patients with Severe Asthma with a high T2 phenotype

    Treatment: Hyperpolarized 129 Xenon

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
Plain-language title
Imaging Airflow Behind Mucus Plugs in Lung Disease With Xenon MRIGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06985225, who can take part
Record updated
1 July 2026